-
Something wrong with this record ?
Design of Multivalent Inhibitors for Preventing Cellular Uptake
V. Schubertová, FJ. Martinez-Veracoechea, R. Vácha,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Antiviral Agents chemistry pharmacology MeSH
- Virus Internalization drug effects MeSH
- Drug Design * MeSH
- Molecular Dynamics Simulation MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Cellular entry, the first crucial step of viral infection, can be inhibited by molecules adsorbed on the virus surface. However, apart from using stronger affinity, little is known about the properties of such inhibitors that could increase their effectiveness. Our simulations showed that multivalent inhibitors can be designed to be much more efficient than their monovalent counterparts. For example, for our particular simulation model, a single multivalent inhibitor spanning 5 to 6 binding sites is enough to prevent the uptake compared to the required 1/3 of all the receptor binding sites needed to be blocked by monovalent inhibitors. Interestingly, multivalent inhibitors are more efficient in inhibiting the uptake not only due to their increased affinity but mainly due to the co-localization of the inhibited receptor binding sites at the virion's surface. Furthermore, we show that Janus-like inhibitors do not induce virus aggregation. Our findings may be generalized to other uptake processes including bacteria and drug-delivery.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035581
- 003
- CZ-PrNML
- 005
- 20191008113050.0
- 007
- ta
- 008
- 191007s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-017-11735-7 $2 doi
- 035 __
- $a (PubMed)28916832
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Schubertová, Veronika $u Faculty of Science, Masaryk University, Brno, Czech Republic. Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Design of Multivalent Inhibitors for Preventing Cellular Uptake / $c V. Schubertová, FJ. Martinez-Veracoechea, R. Vácha,
- 520 9_
- $a Cellular entry, the first crucial step of viral infection, can be inhibited by molecules adsorbed on the virus surface. However, apart from using stronger affinity, little is known about the properties of such inhibitors that could increase their effectiveness. Our simulations showed that multivalent inhibitors can be designed to be much more efficient than their monovalent counterparts. For example, for our particular simulation model, a single multivalent inhibitor spanning 5 to 6 binding sites is enough to prevent the uptake compared to the required 1/3 of all the receptor binding sites needed to be blocked by monovalent inhibitors. Interestingly, multivalent inhibitors are more efficient in inhibiting the uptake not only due to their increased affinity but mainly due to the co-localization of the inhibited receptor binding sites at the virion's surface. Furthermore, we show that Janus-like inhibitors do not induce virus aggregation. Our findings may be generalized to other uptake processes including bacteria and drug-delivery.
- 650 _2
- $a antivirové látky $x chemie $x farmakologie $7 D000998
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a internalizace viru $x účinky léků $7 D053586
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martinez-Veracoechea, Francisco J $u Eesti Energia AS, Lelle 22, 11318, Tallinn, Estonia.
- 700 1_
- $a Vácha, Robert $u Faculty of Science, Masaryk University, Brno, Czech Republic. robert.vacha@mail.muni.cz. Central European Institute of Technology, Masaryk University, Brno, Czech Republic. robert.vacha@mail.muni.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 11689
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28916832 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191008113506 $b ABA008
- 999 __
- $a ok $b bmc $g 1452241 $s 1074131
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c 1 $d 11689 $e 20170915 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20191007